The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Needle-Free Diabetes Care-Global Market Insights and Sales Trends 2025
Synopsis
Diabetes is a metabolic disorder in this condition person will have high blood glucose levels than the normal blood glucose. This is mainly due to inadequate insulin production or body cells are unable to respond to the produced insulin in the body or both. Symptoms of Diabetes are hyperglycemic conditions, excessive excretion of urine, hunger, thirst, weight loss, fatigue and impaired vision. Diabetes is classified into Type 1 and Type 2 Diabetes.
The global Needle-Free Diabetes Care market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Needle-Free Diabetes Care in various end use industries. The expanding demands from the Consumer, Diagnostic Centers and Hospitals and Clinics,, are propelling Needle-Free Diabetes Care market. Insulin Patches, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Jet Injectors segment is estimated at % CAGR for the next seven-year period.
Based on the end user, Diagnostic centers is expected to have the large market share than the others. This is because of the majorly the diabetes diagnosis tests are usually takes place in the diagnostic centers.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Needle-Free Diabetes Care, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Needle-Free Diabetes Care market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Needle-Free Diabetes Care market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Needle-Free Diabetes Care sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Needle-Free Diabetes Care covered in this report include Antares Pharma, European Pharma Group, Johnson and Johnson, Injex UK, Echo Therapeutics and MannKind Corporation, etc.
The global Needle-Free Diabetes Care market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Antares Pharma
European Pharma Group
Johnson and Johnson
Injex UK
Echo Therapeutics
MannKind Corporation
Global Needle-Free Diabetes Care market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Needle-Free Diabetes Care market, Segment by Type:
Insulin Patches
Jet Injectors
Insulin Pens
Insulin Pumps
Insulin Infuser
Global Needle-Free Diabetes Care market, by Application
Consumer
Diagnostic Centers
Hospitals and Clinics
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Needle-Free Diabetes Care companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Diabetes is a metabolic disorder in this condition person will have high blood glucose levels than the normal blood glucose. This is mainly due to inadequate insulin production or body cells are unable to respond to the produced insulin in the body or both. Symptoms of Diabetes are hyperglycemic conditions, excessive excretion of urine, hunger, thirst, weight loss, fatigue and impaired vision. Diabetes is classified into Type 1 and Type 2 Diabetes.
The global Needle-Free Diabetes Care market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Needle-Free Diabetes Care in various end use industries. The expanding demands from the Consumer, Diagnostic Centers and Hospitals and Clinics,, are propelling Needle-Free Diabetes Care market. Insulin Patches, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Jet Injectors segment is estimated at % CAGR for the next seven-year period.
Based on the end user, Diagnostic centers is expected to have the large market share than the others. This is because of the majorly the diabetes diagnosis tests are usually takes place in the diagnostic centers.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Needle-Free Diabetes Care, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Needle-Free Diabetes Care market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Needle-Free Diabetes Care market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Needle-Free Diabetes Care sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Needle-Free Diabetes Care covered in this report include Antares Pharma, European Pharma Group, Johnson and Johnson, Injex UK, Echo Therapeutics and MannKind Corporation, etc.
The global Needle-Free Diabetes Care market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Antares Pharma
European Pharma Group
Johnson and Johnson
Injex UK
Echo Therapeutics
MannKind Corporation
Global Needle-Free Diabetes Care market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Needle-Free Diabetes Care market, Segment by Type:
Insulin Patches
Jet Injectors
Insulin Pens
Insulin Pumps
Insulin Infuser
Global Needle-Free Diabetes Care market, by Application
Consumer
Diagnostic Centers
Hospitals and Clinics
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Needle-Free Diabetes Care companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Needle-Free Diabetes Care
1.1 Needle-Free Diabetes Care Market Overview
1.1.1 Needle-Free Diabetes Care Product Scope
1.1.2 Needle-Free Diabetes Care Market Status and Outlook
1.2 Global Needle-Free Diabetes Care Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Needle-Free Diabetes Care Market Size by Region (2018-2029)
1.4 Global Needle-Free Diabetes Care Historic Market Size by Region (2018-2023)
1.5 Global Needle-Free Diabetes Care Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Needle-Free Diabetes Care Market Size (2018-2029)
1.6.1 North America Needle-Free Diabetes Care Market Size (2018-2029)
1.6.2 Europe Needle-Free Diabetes Care Market Size (2018-2029)
1.6.3 Asia-Pacific Needle-Free Diabetes Care Market Size (2018-2029)
1.6.4 Latin America Needle-Free Diabetes Care Market Size (2018-2029)
1.6.5 Middle East & Africa Needle-Free Diabetes Care Market Size (2018-2029)
2 Needle-Free Diabetes Care Market by Type
2.1 Introduction
2.1.1 Insulin Patches
2.1.2 Jet Injectors
2.1.3 Insulin Pens
2.1.4 Insulin Pumps
2.1.5 Insulin Infuser
2.2 Global Needle-Free Diabetes Care Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Needle-Free Diabetes Care Historic Market Size by Type (2018-2023)
2.2.2 Global Needle-Free Diabetes Care Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Needle-Free Diabetes Care Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Needle-Free Diabetes Care Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Needle-Free Diabetes Care Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Needle-Free Diabetes Care Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Needle-Free Diabetes Care Revenue Breakdown by Type (2018-2029)
3 Needle-Free Diabetes Care Market Overview by Application
3.1 Introduction
3.1.1 Consumer
3.1.2 Diagnostic Centers
3.1.3 Hospitals and Clinics
3.2 Global Needle-Free Diabetes Care Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Needle-Free Diabetes Care Historic Market Size by Application (2018-2023)
3.2.2 Global Needle-Free Diabetes Care Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Needle-Free Diabetes Care Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Needle-Free Diabetes Care Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Needle-Free Diabetes Care Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Needle-Free Diabetes Care Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Needle-Free Diabetes Care Revenue Breakdown by Application (2018-2029)
4 Needle-Free Diabetes Care Competition Analysis by Players
4.1 Global Needle-Free Diabetes Care Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Needle-Free Diabetes Care as of 2022)
4.3 Date of Key Players Enter into Needle-Free Diabetes Care Market
4.4 Global Top Players Needle-Free Diabetes Care Headquarters and Area Served
4.5 Key Players Needle-Free Diabetes Care Product Solution and Service
4.6 Competitive Status
4.6.1 Needle-Free Diabetes Care Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Antares Pharma
5.1.1 Antares Pharma Profile
5.1.2 Antares Pharma Main Business
5.1.3 Antares Pharma Needle-Free Diabetes Care Products, Services and Solutions
5.1.4 Antares Pharma Needle-Free Diabetes Care Revenue (US$ Million) & (2018-2023)
5.1.5 Antares Pharma Recent Developments
5.2 European Pharma Group
5.2.1 European Pharma Group Profile
5.2.2 European Pharma Group Main Business
5.2.3 European Pharma Group Needle-Free Diabetes Care Products, Services and Solutions
5.2.4 European Pharma Group Needle-Free Diabetes Care Revenue (US$ Million) & (2018-2023)
5.2.5 European Pharma Group Recent Developments
5.3 Johnson and Johnson
5.3.1 Johnson and Johnson Profile
5.3.2 Johnson and Johnson Main Business
5.3.3 Johnson and Johnson Needle-Free Diabetes Care Products, Services and Solutions
5.3.4 Johnson and Johnson Needle-Free Diabetes Care Revenue (US$ Million) & (2018-2023)
5.3.5 Injex UK Recent Developments
5.4 Injex UK
5.4.1 Injex UK Profile
5.4.2 Injex UK Main Business
5.4.3 Injex UK Needle-Free Diabetes Care Products, Services and Solutions
5.4.4 Injex UK Needle-Free Diabetes Care Revenue (US$ Million) & (2018-2023)
5.4.5 Injex UK Recent Developments
5.5 Echo Therapeutics
5.5.1 Echo Therapeutics Profile
5.5.2 Echo Therapeutics Main Business
5.5.3 Echo Therapeutics Needle-Free Diabetes Care Products, Services and Solutions
5.5.4 Echo Therapeutics Needle-Free Diabetes Care Revenue (US$ Million) & (2018-2023)
5.5.5 Echo Therapeutics Recent Developments
5.6 MannKind Corporation
5.6.1 MannKind Corporation Profile
5.6.2 MannKind Corporation Main Business
5.6.3 MannKind Corporation Needle-Free Diabetes Care Products, Services and Solutions
5.6.4 MannKind Corporation Needle-Free Diabetes Care Revenue (US$ Million) & (2018-2023)
5.6.5 MannKind Corporation Recent Developments
6 North America
6.1 North America Needle-Free Diabetes Care Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Needle-Free Diabetes Care Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Needle-Free Diabetes Care Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Needle-Free Diabetes Care Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Needle-Free Diabetes Care Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Needle-Free Diabetes Care Market Dynamics
11.1 Needle-Free Diabetes Care Industry Trends
11.2 Needle-Free Diabetes Care Market Drivers
11.3 Needle-Free Diabetes Care Market Challenges
11.4 Needle-Free Diabetes Care Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
